Arkolith/Insider Trading/NAVB/Form 4/A

Witter Malcolm G

DirectorNAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) · full profile →Form 4/A · filed Nov 30, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 30, 2022Grant(A)1K—$0165K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001437749-22-028231) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML